The present invention refers to new compounds useful in the treatment of leishmaniasis and, more particularly, to a series of 5-6-5 triazole-phenyl-thiazole heterocycles capable of inhibiting both activity and dimerization of L. infantum Try R in enzymatic assays at low micromolar concentrations and endowed with potent in vitro activity against promastigote and amastigote forms of Leishmania which indicates a good permeability across the plasma membrane ofthe parasitesPeer reviewedConsejo Superior de Investigaciones Científicas (España), Universidad de AlcaláA1 Solicitud de patente con informe sobre el estado de la técnic
